BioLineRx (BLRX) Shares Outstanding (2015 - 2026)

BioLineRx's Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $3.1 billion for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 105.76% year-over-year to $3.1 billion; the TTM figure through Dec 2025 stood at $3.1 billion (up 105.76% YoY), while the FY2025 annual figure was $3.1 billion, up 105.76% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $3.1 billion, down from $3.3 billion in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $60.0 billion in Q3 2024, with the low at $1.5 billion in Q4 2024.
• The 5-year median for Shares Outstanding (Entity) is $26.0 billion (2022), against an average of $25.5 billion.
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Entity) surged 217.1% in 2021, then sank 95.72% in 2024.
• BioLineRx's Shares Outstanding (Entity) stood at $24.1 billion in 2021, then grew by 16.75% to $28.1 billion in 2022, then gained by 24.47% to $35.0 billion in 2023, then tumbled by 95.72% to $1.5 billion in 2024, then surged by 105.76% to $3.1 billion in 2025.
• Business Quant data shows BLRX's Shares Outstanding (Entity) at $3.1 billion in Q4 2025, $3.3 billion in Q3 2025, and $3.0 billion in Q2 2025.